European Respiratory Journal · 2022 · 18 citations · 25 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyImmunology Of Infectious DiseasesMolecular ImmunologyAntigen RecognitionCell-mediated ImmunityDiagnostic ImmunologyT Cell BiologyTuberculosis DiagnosisTuberculosis Diagnostic TestingBlood-based BiomarkersCd4 Positive T Cell ResponsesCd4 Positive T CellsHigh-sensitivity AssaysMycobacterium Tuberculosis InfectionT-cell Immune ResponsesTuberculosis Antigen DetectionTuberculosis Diagnostics
Background Rapid and reliable diagnostic work-up of tuberculosis (TB) remains a major healthcare goal. In particular, discrimination of TB infection from TB disease with currently available diagnostic tools is challenging and time consuming. This study aimed at establishing a standardised blood-based assay that rapidly and reliably discriminates TB infection from TB disease based on multiparameter analysis of TB antigen-reactive CD4 + T-cells acting as sensors for TB stage-specific immune status. Methods 157 HIV-negative subjects with suspected TB infection or TB disease were recruited from local tertiary care hospitals in Berlin (Germany). Peripheral blood mononuclear cells were analysed for CD4 + T-cells reactive to the Mycobacterium tuberculosis antigens purified protein derivative and early secretory antigenic target 6 kDa/culture filtrate protein 10. The activation state of TB antigen-reactive T-cells, identified by surface expression of CD154, was evaluated according to the expression profile of proliferation marker Ki-67 and activation markers CD38 and HLA-DR. Using data from 81 subjects with clinically confirmed TB infection (n=34) or culture-proven pulmonary or extrapulmonary TB disease (n=47), 12 parameters were derived from the expression profile and integrated into a scoring system. Results Using the scoring system, our assay (TB-Flow Assay) allowed reliable discrimination of TB infection from both pulmonary and extrapulmonary TB disease with high sensitivity (90.9%) and specificity (93.3%) as was confirmed by Monte-Carlo cross-validation. Conclusion With low time requirement, ease of sample collection, and high sensitivity and specificity both for pulmonary and extrapulmonary TB disease, we believe this novel standardised TB-Flow Assay will improve the work-up of patients with suspected TB disease, supporting rapid TB diagnosis and facilitating treatment decisions.
25
Qingsong Xu, Yi‐Zeng Liang · Chemometrics and Intelligent Laboratory Systems · 2001 · 1.1K citations
Tuberculosis surveillance and monitoring in Europe 2012.
Masoud Dara, Kristin Kremer, Emma Huitric et al. · 2012 · 555 citations
Public Health, Infectious Disease Control, Infectious Diseases +14